AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 242: E411-E417, 1982;
0193-1849/82 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Itallie, C. M.
Right arrow Articles by Fernstrom, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Itallie, C. M.
Right arrow Articles by Fernstrom, J. D.

AJP - Endocrinology and Metabolism, Vol 242, Issue 6 411-E417, Copyright © 1982 by American Physiological Society

ARTICLES

Osmolal effects on vasopressin secretion in the streptozotocin-diabetic rat

C. M. Van Itallie and J. D. Fernstrom

To determine the relationships between serum levels of arginine vasopressin (AVP) and serum osmolality and sodium in diabetic rats, we measured these variables in streptozotocin-diabetic and normal animals treated with water, isotonic saline, or hypertonic saline. Serum osmolality was higher and sodium lower in untreated diabetics than in controls; these variables increased in both groups after hypertonic saline. Serum AVP levels (measured by radioimmunoassay in Amberlite-extracted serum) were 2.3 +/- 0.5 and 9.8 +/- 1.7 pg/ml in control and diabetic rats, respectively, injected with isotonic saline. AFter injection of hypertonic saline, serum AVP levels rose to 14.5 +/- 2.3 pg/ml in controls and 18.7 +/- 1.7 pg/ml in diabetics. Water injection decreased serum AVP in diabetics (as in normals), but only to 5.8 +/- 1.0 pg/ml. To assess indirectly whether the chronically high levels of AVP in serum had an impact on kidney function, diabetic rats were studied after passive immunization with an anti-AVP serum. This treatment increased urine flow and decreased urine osmolality in dehydrated diabetic rats. Taken together, these data affirm in diabetic rats, as in humans, the occurrence of 1) elevated steady-state levels of AVP in serum; 2) abnormal sensitivity of AVP secretion to changes in serum sodium and osmolality; and 3) an apparently intact end-organ responsiveness to AVP.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Zheng, W. G. Mayhan, K. R. Bidasee, and K. P. Patel
Blunted nitric oxide-mediated inhibition of sympathetic nerve activity within the paraventricular nucleus in diabetic rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R992 - R1002.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Bardoux, H. Martin, M. Ahloulay, F. Schmitt, N. Bouby, M.-M. Trinh-Trang-Tan, and L. Bankir
Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: Study in vasopressin-deficient Brattleboro rats
PNAS, August 31, 1999; 96(18): 10397 - 10402.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online